ReviewFrontiers in physiology2026

Novel therapeutic strategies targeting mitochondrial quality control for metabolic dysfunction-associated steatotic liver disease.

Huiling Zuo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.